Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet — FDA Drug Shortage
The FDA lists a drug shortage record for Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet (tablet) from SpecGx LLC with status Current. The shortage was first posted on Oct 12, 2022. Reported reason: Demand increase for the drug
Shortage details
- Status
- Current
- Company
- SpecGx LLC
- Package NDC
- 0406-8894-01
- Dosage Form
- Tablet
- Presentation
- Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg (NDC 0406-8894-01)
- Initial Posting
- Oct 12, 2022
Reason
Demand increase for the drug